MiNK Therapeutics, Inc. (INKT)
Nasdaq: INKT · Biological Products, (No Diagnostic Substances) · New York, NY · filing with the SEC since 2021
Who runs MiNK Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Buell Jennifer
Chief Executive Officer. First filing Oct 2021, latest Oct 14, 2026, 1 filing in all.
Officers reporting now
3
of 9 people with a filing in the last fifteen months
Directors reporting now
6
14 people on the record since 2021
Officerssales are open-market, Oct 14, 2025 to Oct 14, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Buell Jennifer | Chief Executive Officer | Oct 2021 | Oct 14, 2026 | 1 · $100,000 |
| Orilall Melissa | Principal Financial Officer | Apr 2026 | Apr 9, 2026 | none |
| Charette Austin | Principal Accounting Officer | Mar 2026 | Mar 23, 2026 | none |
Directorssales are open-market, Oct 14, 2025 to Oct 14, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Behner Peter | director | Oct 2021 | Sep 2, 2026 | none |
| Corvese Brian | director | Oct 2021 | Sep 2, 2026 | none |
| Holcomb John Bradley | director | Dec 2025 | Sep 2, 2026 | none |
| Ryan Barbara | director | Oct 2021 | Sep 2, 2026 | 8 · $0.00 |
| Wiinberg Ulf | director | Oct 2021 | Sep 2, 2026 | none |
| Kadlec Robert Peter | director | Dec 2024 | Dec 3, 2025 | none |
Earlier names on the record6, newest filing first
Van Dijk Marcus Antonius · officer · last filing Jan 2024Agenus Inc · 10% owner · last filing Oct 2023Baldoni John · director · last filing Sep 2023Armen Garo H · director · last filing May 2023Klaskin Christine M · officer · last filing Oct 2021Flamenbaum Walter Md · director · last filing Oct 2021
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.